In a pilot RCT of 20 adults with treatment-resistant depression, psilocybin 25 mg vs 1 mg (with psychological support) did not significantly improve anhedonia (DARS) at week 1 (difference 11.2; p=0.073); secondary measures, including MADRS, favoured 25 mg.
RCTn = 20
Novick et al. Effects of psilocybin with psychological support on anhedonia in treatment-resistant depression: A randomized controlled pilot trial